DRUG DELIVERY SYSTEM TARGETING LACRIMAL GLAND - SANTEN PHARMACEUTICAL CO LTD

Title:

DRUG DELIVERY SYSTEM TARGETING LACRIMAL GLAND

Document Type and Number:

WIPO Patent Application WO/2016/159351

Kind Code:

A1

Abstract:

Provided is a non-invasive drug delivery system for efficiently delivering a drug to the lacrimal gland, said system being characterized in that the drug is administered to the eyelid skin once a day.

Inventors:

OKI KENJI (JP)
ASADA HIROYUKI (JP)
MIYAZAKI TATSUYA (JP)
INAGAKI KOJI (JP)

Application Number:

PCT/JP2016/060928

Publication Date:

October 06, 2016

Filing Date:

April 01, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SANTEN PHARMACEUTICAL CO LTD (JP)

International Classes:

A61K9/06; A61K9/107; A61K31/22; A61K31/27; A61K47/06; A61K47/14; A61P27/02

Domestic Patent References:

WO2005113002A1

2005-12-01

Foreign References:

JP2011500683A	2011-01-06
JP2011515494A	2011-05-19
JPH06509801A	1994-11-02

Attorney, Agent or Firm:

TSUKUNI & ASSOCIATES et al. (JP)
Patent business corporation Tsukuni (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: DRY EYE THERAPEUTIC AGENT HAVING AS ACTIVE INGREDIENT NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ...

Next Patent: POROUS ELECTRODE BASE MATERIAL AND MANUFACTURING METHOD THEREFOR